Action of m-tyrosine in experimental models: evidence for possible antiparkinsonian activity.
D000818:Animals; D000978:Antiparkinson Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D001545:Benserazide / Q000494:pharmacology; D001923:Brain Chemistry; D003714:Denervation; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology; D000882:Haplorhini; D006651:Histocytochemistry; D006892:Hydroxydopamines / Q000494:pharmacology; D008954:Models, Biological; D051381:Rats; D011955:Receptors, Drug / Q000187:drug effects; D012110:Reserpine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013050:Spectrometry, Fluorescence; D013378:Substantia Nigra / Q000187:drug effects; D014202:Tremor / Q000139:chemically induced; D014443:Tyrosine / Q000008:administration & dosage / Q000032:analysis / Q000494:pharmacology*
D000978:Antiparkinson Agents; D006892:Hydroxydopamines; D011955:Receptors, Drug; D014443:Tyrosine; D004295:Dihydroxyphenylalanine; D001545:Benserazide; D012110:Reserpine